C M P Medica LLC * The Oncology Group

SHERPA: Unknown

People

  1. Iyengar
    Iyengar
  2. Kris
    Kris
  3. Preeshagul
    Preeshagul
  4. Schram
    Schram
  5. Stein
    Stein
  6. Yu
    Yu

Groups

  1. Department of Medicine (9)
  2. Solid Tumor Oncology Division (8)
  3. Breast Medicine Service (5)
  4. Population Sciences Research Program (5)
  5. Survivorship Research (5)
  6. Thoracic Oncology (2)
  7. Adult Leukemia (1)
  8. Center for Hematologic Malignancies (1)
  9. Early Drug Development Service (1)
  10. Gynecologic Medicine Service (1)
Search Within
  1. "Editorial"
Formats
  1. Editorial (10)
Groups
  1. Department of Medicine (9)
  2. Solid Tumor Oncology Division (8)
  3. Breast Medicine Service (5)
  4. Population Sciences Research Program (5)
  5. Survivorship Research (5)
  6. Thoracic Oncology (2)

More Groups

People
  1. Neil Iyengar (5)
  2. Alison Schram (1)
  3. Eytan Stein (1)
  4. Helena Yu (1)
  5. Isabel Preeshagul (1)
  6. Marjorie Zauderer (1)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (1)
  4. 2021 (3)
  5. 2020 (1)
Publications
  1. Oncology (Norwalk) (10)

Results (10)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Things you should know about managing ALK plus metastatic NSCLC
    Editorial

    Kris, M. G.; Gainor, J.; Preeshagul, I.; Yu, H. A.
    Oncology (Norwalk) (2025)

    Fulltext@MSK | Save
  • Assessing 2024 oncology advances and looking ahead
    Editorial

    Iyengar, N. M.
    Oncology (Norwalk) (2024)

    Fulltext@MSK | Save
  • Co-Editor-in-Chief Introduction: Priorities and new directions
    Editorial

    Iyengar, N. M.
    Oncology (Norwalk) (2024)

    Fulltext@MSK | Save
  • Updates in breast cancer care: From the 41st Annual Miami Breast Cancer Conference
    Editorial

    Iyengar, N. M.
    Oncology (Norwalk) (2024)

    Fulltext@MSK | Save
  • Defining a space for NRG1 fusion–Positive tumors in lung and GI cancers
    Editorial

    Spira, A. I.; Macarulla, T.; Neuzillet, C.; Sabari, J. K.; Schram, A.; Van Cutsem, E.
    Oncology (Norwalk) (2024)

    Fulltext@MSK | Save
  • Co–editor-in-chief introduction: Priorities and new directions
    Editorial

    Iyengar, N. M.
    Oncology (Norwalk) (2023)

    Fulltext@MSK | Save
  • Relapsed/refractory HER2+ metastatic breast cancer
    Editorial

    Brufsky, A. M.; Gadi, V. K.; Hurvitz, S. A.; Iyengar, N. M.
    Oncology (Norwalk) (2021)

    Fulltext@MSK | Save
  • Management of chemotherapy-ineligible acute myeloid leukemia: Beyond hypomethylating agent monotherapy
    Editorial

    Stein, E. M.
    Oncology (Norwalk) (2021)

    Fulltext@MSK | Save
  • Updates in HER2-positive metastatic breast cancer
    Editorial

    Gadi, V. K.; Iyengar, N.; Isaacs, C.; Kaklamani, V.
    Oncology (Norwalk) (2021)

    Fulltext@MSK | Save
  • FDA approves nivolumab plus ipilimumab for previously untreated unresectable malignant pleural mesothelioma - Comment
    Editorial

    Zauderer, M. G.
    Oncology (Norwalk) (2020)

    Fulltext@MSK | Save

    • C M P Medica LLC * The Oncology Group – authorized name for: